Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jun 20.
Published in final edited form as: Int J Cardiol. 2012 Oct 18;166(2):543–545. doi: 10.1016/j.ijcard.2012.09.189

Complex assessment of the Temporal Lability of Repolarization

Lichy Han 1, Alan Cheng 2, Sanjoli Sur 1, Gordon F Tomaselli 2, Ronald D Berger 2, Larisa G Tereshchenko 2
PMCID: PMC3553311  NIHMSID: NIHMS412364  PMID: 23084544

Stochastic fluctuations of IKs in the presence of cell-to-cell uncoupling leads to temporal variability of action potential duration and subsequent early afterdepolarizations, which occur in late phase 2 or phase 3 of the cardiac action potential, could propagate through cardiac tissue and generate ventricular arrhythmias (1;2). However, surface ECG imposes well-recognized limitations for repolarization assessment: dependence on particular ECG lead axis and inaccuracies in the T end detection. In contrast, vectorcardiograms (VCGs) have advantages in their description of repolarization(3). Recently we proposed a novel 3-dimensional (3-D) ECG method to assess temporal repolarization lability(4;5). However, the complexity of spatial T-vector movements over time makes it unlikely that any single method would describe temporal lability of repolarization in full. Therefore, the goal of this study was to develop a comprehensive set of markers of temporal lability of repolarization in a discriminating model.

We conducted age-, gender-, and race- matched Case-Control study. All study participants gave written, informed consent upon entering the study. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology(6). Participants of ongoing prospective observational cohort study of patients with structural heart disease and a primary prevention ICD were included in this analysis (NCT00733590)(5). Healthy subjects participated in the Intercity Digital Electrocardiogram Alliance (IDEAL) study, which was previously described elsewhere(7). Baseline modified Frank surface orthogonal ECGs were recorded at rest for approximately 5 minutes before the implantation of an ICD using a PC ECG machine (Norav Medical Ltd, Thornhill, ON, Canada, sampling frequency 1000 Hz, amplitude resolution of 2.44 µV) in Cases, and using the SpaceLab-Burdick digital Holter (SpaceLab-Burdick, Inc., Deerfield, WI, sampling frequency 1000 Hz, amplitude resolution of 4.88µV) in Controls. Blinded ECG analysis was performed using custom MATLAB (MathWorks, Inc, Natick, MA) software. Recordings in atrial fibrillation, premature ventricular complexes (PVCs) and the subsequent beat were excluded from analysis; only sinus beats were analyzed. Mean spatial TT’ angle was calculated as a measure of beat-to-beat spatial T axis variability, as the angle between two consecutive T vectors using the definition of the inner product. The area of the T-loop was calculated using successive triangles along the loop from the peak to the origin point. Variability of spatial T vector magnitude and that of spatial T-loop area were measured as their respective variances. Additionally, the ratio of the T peaks cloud volume to the R peaks cloud volume was calculated as previously described(4;5). Normalized T loop area variance (TareaVN) was calculated according to the equation:

TareaVN=log[Variance of spatial Tloop area(Mean spatial Tloop area)2]

Normalized T amplitude variance (TampVN) was calculated according to the equation:

TampVN=log[Variance of spatial T vector amplitude(Mean spatial T vector amplitude)2]

The QT interval was calculated as the time from beginning of Q or R wave (8) to the end of the T-wave (9), averaged over all beats on all leads. QT interval was corrected for heart rate using Bazett’s formula. QT variance was calculated as the variance of the QT interval, and QT variability index (QTVI) was calculated(10).

A classification model was implemented to distinguish healthy state of repolarization lability in Cases and Controls. For this purpose, QTVI, mean spatial TT’ angle, TampVN, and TareaVN entered the PCA model. The PCA technique was employed to combine the repolarization lability variables and to develop a comprehensive set of repolarization lability markers. Then, a canonical linear discriminant analysis was applied to correlate the differences in repolarization lability of the relevant principal component scores to the health state. The Student’s t-test was applied to compare the scores of the first principal component of the Cases and Controls. Sensitivity and specificity of the comprehensive repolarization lability score were calculated. The proposed comprehensive repolarization lability score for each study participant was calculated according to the following equation:

RL score=FWTT·ZSTT+FWTampVN·ZSTampVN+FWTareaVN·ZSTareaVN+FWQTVI·ZSQTVI,

where FW is the scoring coefficient, or optimal regression weight, determined for each variable in the PCA model for the 1st Principal Component, and ZS is the Z-Score of the parameter in our population for each individual subject. For example, the Z-Score for Subject A for TT’ angle is calculated as follows:

ZSTT=Subject As TT AngleMean TT AngleStd Dev of TT Angle

Results showed that Cases and Controls were well-matched by age, gender, and race. All study participants were Caucasian. Amongst Cases, two-thirds of patients (n=42, 68%) had non-ischemic cardiomyopathy, and half of the patients (n=31, 50%) had NYHA class III HF. The mean ejection fraction was 22.4±10.3%.

Repolarization lability PCA model included mean spatial TT’ angle, QTVI, TampVN, and TareaVN. After extracting the PCA vectors and scores, it was verified that the first two Principal Components represent about 85% of all variance of the dataset (PC1 = 51.4%, PC2 = 34.0%, PC3 = 11.1 %, PC4 = 3.5%). Interestingly, multiple repolarization lability parameters contributed to a similar extent. All studied repolarization lability parameters correlated with each other. The first factor, PC1, which accounted for the greatest variance at 51.4%, was the most heavily loaded by spatial TT’ angle (0.506) and QTVI (0.631). The second factor, PC2, accounting for 34.0% of the variance, was most heavily loaded by TampVN (0.658) and TareaVN (0.580). Repolarizatoin lability score, calculated using the PCA scoring coefficients, showed a remarkable, statistically significant difference for discriminating Cases from Controls (Figure 1). Canonical linear discriminant analysis showed that taking all 4 aforementioned repolarization lability parameters separates Cases from Controls with 100% sensitivity and 98.4% specificity (canonical correlation coefficient 0.969, Eigen-value 15.6; p<0.0001).

Figure 1.

Figure 1

Boxplots of 3-dimentional ECG repolarization lability parameters : A. Mean spatial TT’ angle; B. Normalized variance of spatial T vector amplitude; C. Normalized variance of T spatial loop area; D. Spatial T vector amplitude; E. QT interval variance. F. Boxplot of the scores of the 1st principal component of the final PCA model (eigenvalue = 2.06; accounted for 51.4% variability) in Cases and Controls. Median (white horizontal line crossing the box) and interquartile range [IQR] (box) of corresponding variable values. Whiskers specify the adjacent values, defined as the most extreme values within 1.5 IQR of the nearer quartile.

Thus, our study showed that patients with structural heart disease and systolic dysfunction are characterized by significantly increased temporal repolarization lability as measured by increased spatial TT’ angle, by increased normalized variance of T loop area, and by increased QTVI. The repolarization lability score developed (composed of spatial TT’ angle, QTVI, normalized variance of spatial T vector magnitude, and normalized variance of T loop area) nearly perfectly differentiated healthy subjects from patients with structural heart disease and primary prevention ICD (100% sensitivity and 98.4% specificity). Future studies are needed to determine the predictive value of repolarization lability score in different patient populations.

Table 1.

Clinical characteristics and ECG parameters in Cases and Controls

Parameter Cases, n=62 Controls, n=62 P
Age ± SD, y 46.5±8.4 45.8±8.8 0.595
Male Gender, n(%) 33(53) 34(55) 0.857
Systolic BP±SD, mmHg 121.4±22.0 118.9±11.0 0.421
Diastolic BP±SD, mmHg 69.2±9.65 76.15±8.46 0.0001
BMI 29.9±5.5 23.9±3.1 <0.0001
Smokers, n(%) 36(67) 22(35) 0.001

Mean heart rate, bpm 72.4±11.9 64.8±9.8 0.0002
Heart rate variance, ms2 756.4(322.9–1296.9) 742.3(434.4–1723.0) 0.257
Mean QTc 475.6±39.0 411.7±20.3 <0.0001
QT interval variance, ms2 552.1(326.5–837.3) 203.3(149.7–290.4) 0.0047
QTVI 0.51±0.52 −2.17±0.64 <0.0001
Mean spatial T-T’ angle, deg 5.5(3.8–8.5) 3.0(2.2–4.2) <0.0001
6.9±5.3 3.4±1.6 <0.0001
Mean T vector amplitude, mV 0.53±0.33 0.71±0.25 0.0007
T vector amplitude variance, mV2 .001(.0005–.002) .094(.053–.134) <0.0001
TampVN −5.2±1.3 −1.6±1.0 <0.0001
Mean T Loop Area, mV2 55.4(25.3–116.5) 122.6(78.0–175.6) 0.0003
T Loop Area Variance, mV4 80.7(17.6–242.5) 142.6(55.7–288.3) 0.1054
TareaVN −3.5±2.1 −4.6±0.9 0.0004
T/R peaks cloud volume ratio 0.19(0.10–0.34) 0.23(0.15–0.41) 0.107

QTVI=QT variability index; TampVN= Normalized variance of spatial T vector amplitude; TareaVN= normalized variance of spatial T loop area.

Acknowledgments

Financial support & Conflict of interest: NIH HL R01 091062 (Gordon Tomaselli), AHA 10CRP2600257 (Larisa Tereshchenko).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Potential Conflict of Interest: Ronald Berger holds a patent on the technology for QT variability analysis.

Reference List

  • 1.Weiss JN, Garfinkel A, Karagueuzian HS, Chen PS, Qu Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm. 2010 Dec;7(12):1891–1899. doi: 10.1016/j.hrthm.2010.09.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pueyo E, Corrias A, Virag L, et al. A multiscale investigation of repolarization variability and its role in cardiac arrhythmogenesis. Biophys J. 2011 Dec 21;101(12):2892–2902. doi: 10.1016/j.bpj.2011.09.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kors JA, van HG, van Bemmel JH. QT dispersion as an attribute of T-loop morphology. Circulation. 1999 Mar 23;99(11):1458–1463. doi: 10.1161/01.cir.99.11.1458. [DOI] [PubMed] [Google Scholar]
  • 4.Han L, Tereshchenko LG. Lability of R- and T-wave peaks in three-dimensional electrocardiograms in implantable cardioverter defibrillator patients with ventricular tachyarrhythmia during follow-up. J Electrocardiol. 2010 Nov;43(6):577–582. doi: 10.1016/j.jelectrocard.2010.05.011. [DOI] [PubMed] [Google Scholar]
  • 5.Tereshchenko LG, Han L, Cheng A, et al. Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients. Heart Rhythm. 2010 Nov;7(11):1606–1613. doi: 10.1016/j.hrthm.2010.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Coats AJ, Shewan LG. Statement on authorship and publishing ethics in the international journal of cardiology. Int J Cardiol. 2011 Dec 15;153(3):239–240. doi: 10.1016/j.ijcard.2011.10.119. [DOI] [PubMed] [Google Scholar]
  • 7.Couderc JP, Xiaojuan X, Zareba W, Moss AJ. Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol. 2005 Jan;10(1):25–34. doi: 10.1111/j.1542-474X.2005.00593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zong W, Moody GB, Jiang D. A robust open-source algorithm to detect onset and duration of QRS complexes. Comput Cardiol. 2003 Sep 21;33:737–740. [Google Scholar]
  • 9.Zong W, Saeed M, Heldt T. A QT interval detection algorithm based on ECG curve length transform. Comput Cardiol. 2006 Sep 17;33:377–380. [Google Scholar]
  • 10.Berger RD. QT variability. J Electrocardiol. 2003;36(Suppl):83–87. doi: 10.1016/j.jelectrocard.2003.09.019. [DOI] [PubMed] [Google Scholar]

RESOURCES